X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.ema.europa.eu/en/documents/overview/febuxostat-krka-epar-medicine-overview_en.pdf
https://www.pharmacompass.com/pdf/news/krka-dd-novo-mestos-febuxostat-krka-febuxostat-receives-approval-in-europe-1553940289.pdf
https://www.pharmacompass.com/pdf/news/krka-dd-pemetrexed-receives-approval-in-europe-1528520829.pdf
https://www.pharmacompass.com/pdf/news/krka-dd-novo-mestos-efavirenz-emtricitabine-tenofovir-disoproxil-receives-approval-in-europe-1519283024.pdf
https://www.pharmacompass.com/pdf/news/krka-dd-novo-mestos-darunavir-receives-approval-in-europe-1517032602.pdf
http://www.pharmatimes.com/news/eu_approves_cv_benefit_claim_for_novos_victoza_1199577
https://www.pharmacompass.com/pdf/news/krka-dd-novo-mesto-emtricitabinetenofovir-disoproxil-receives-approval-in-europe-1497089310.pdf
https://www.pharmacompass.com/pdf/news/krka-dd-novo-mestos-emtricitabine-tenofovir-disoproxil-krka-receives-approval-in-europe-1491372117.pdf
http://www.prnewswire.com/news-releases/the-top-100-manufacturers-of-generic-pharmaceuticals-worldwide-300380245.html
http://www.pharmatimes.com/news/eight_medicines_win_chmp_nod_1167254
Market Place
Share 
